|
Index of reports
> Cases resulting in death (2)
> Cases with Anorexia (2)
Below is the selection of adverse event reports related to MS Contin (Morphine) that includes cases resulting in death where reactions include anorexia.
Adverse event in male receiving MS Contin (Morphine)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-19
Patient: male, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Renal Impairment, Anorexia, Lymphangiosis Carcinomatosa, Constipation
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 5 mg/kg, q2w
Indication: Colorectal Cancer
Start date: 2005-12-07
End date: 2006-08-01
Fluorouracil
Dosage: 400 mg/ml, q2w
Indication: Colorectal Cancer
Start date: 2005-12-07
End date: 2006-08-02
Fluorouracil
Dosage: 600 mg/m2, q2w
Start date: 2005-12-07
End date: 2006-08-03
Leucovorin Calcium
Dosage: 100 mg/m2, q2w
Indication: Colorectal Cancer
Start date: 2005-12-07
End date: 2006-08-08
Morphine HCL Elixir
Dosage: 10 mg, bid
Indication: Cancer Pain
Start date: 2005-11-30
MS Contin
Dosage: 60 mg, unk
Indication: Cancer Pain
Start date: 2006-01-07
Oxaliplatin
Dosage: 85 mg/m2, q2w
Indication: Colorectal Cancer Metastatic
Start date: 2005-12-07
End date: 2006-08-01
Adverse event in 73 year old male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-07-19
Patient: 73 year old male
Adverse reactions / side effects: Metastatic Neoplasm, Malaise, Restlessness, Anorexia, Blindness, Antisocial Behaviour
Adverse event resulted in: death, disablity
Suspect drug(s):
MS Contin (Morphine)
|
